From pioneer to expert: Dr CS Ho’s journey in the evolution of clinical mass spectrometry

Dr Chung Shun โ€œCSโ€ Ho, pioneer in mass spectrometry, gives an overview of how the technology and its associated tools have evolved from his 1995 debut. In this episode of Leaders in Conversation with Ronald Lo, General Manager of Roche Diagnostics Hong Kong, Dr Ho recounts how mass spectrometry started from a niche discipline to the evolved, integrated machinery it is today. When he first started at The Chinese University of Hong Kong, Dr Ho has been at the helm of working with mass spectrometry since its introduction to the university. Years of experimenting with it has led to discoveries in better testing techniques, analysis with upgraded accompanying software, and laboratory workflows. Improving skills in mass spectrometry is only one part of it, Dr Ho also enjoys that community of like-minded researchers and professionals he has encountered in this journey of clinical mass spectrometry.

Dr Chung Shun โ€œCSโ€ Ho, pioneer in mass spectrometry, gives an overview of how the technology and its associated tools have evolved from his 1995 debut. In this episode of Leaders in Conversation with Ronald Lo, General Manager of Roche Diagnostics Hong Kong, Dr Ho recounts how mass spectrometry started from a niche discipline to […]

From pioneer to expert: Dr CS Ho’s journey in the evolution of clinical mass spectrometry Read More ยป

Beyond the bite: why blood transfusion safety matters amidst the global dengue surge

dengue blood transfusion

Dengue cases have surged worldwide during the 2023-24 outbreak season, with the WHO reporting close to a historic high of over five million cases and more than 5000 dengue-related deaths in over 80 countries. [1] Dengue is capable of causing a transfusion-transmitted infection, with several case reports, including a case of severe dengue haemorrhagic fever.

Beyond the bite: why blood transfusion safety matters amidst the global dengue surge Read More ยป

Why early CSF testing is a game-changer for Alzheimerโ€™s disease in China

Alzheimerโ€™s disease in China

In this fourth issue of The Value of Diagnostics interview series, Professor Li Xia highlights the specialised role of the Geriatric Psychiatry Department at the Shanghai Mental Health Center in managing cognitive impairment. Unlike neurology departments that focus primarily on cerebrovascular or neurological causes, this department offers “whole-course management” encompassing cognitive function, emotional well-being, and

Why early CSF testing is a game-changer for Alzheimerโ€™s disease in China Read More ยป

The value of rapid diagnostics: spotlighting POCT in Malaysia’s Poliklinik Ar Razi

poct, rapid poct, rapid diagnostics, point-of-care testing

Dr Ain and Dr Farhan, Principal Doctors at Poliklinik Ar Razi in Kuantan, Malaysia, discuss the transformative impact of Point-of-Care Testing (POCT) on their 24-hour primary care facility. Serving a community of approximately 2,000 patients monthly, the clinic manages a split of chronic non-communicable diseases โ€“ e.g. diabetes and hypertension โ€“ and acute communicable illnesses.

The value of rapid diagnostics: spotlighting POCT in Malaysia’s Poliklinik Ar Razi Read More ยป

The practical benefits of HCV antigen-antibody dual assay: Q&A with Prof Tawesak Tanwandee

hcv

Professor Tawesak Tanwandee, Professor of Gastroenterology at Mahidol Universityโ€™s Siriraj Hospital, sits down to discuss how the HCV dual assay helps to streamline diagnosis and reduce patient dropout.ย  The HCV dual assay represents a significant shift from conventional screening by providing independent antigen and antibody results from a single test that delivers results in under

The practical benefits of HCV antigen-antibody dual assay: Q&A with Prof Tawesak Tanwandee Read More ยป

Co-creating change beyond the machine: why effective total lab automation starts with its people

total lab automation, change management, lab automation

In healthcare, the margin between life and death is measured by timely and precise clinical intervention. With diagnostics influencing the vast majority of clinical decisions [1], the laboratory serves as the definitive point of clarity โ€“ where clinical certainty calls, the lab answers.ย  To meet surging testing demands, labs are pivoting to total lab automation

Co-creating change beyond the machine: why effective total lab automation starts with its people Read More ยป

Why expanding access to accurate dengue tests is a critical need in Asia

Why expanding access to accurate dengue tests is a critical need in Asia thumbnail

The viral infection known as dengue is an increasing public health threat. In 2024, the World Health Organisation received reports of 14.6 million cases of this mosquito-borne virus โ€“ a historic high, with infections endemic in more than 100 countries [1]. That number is presumed to be a significant undercount; experts estimate that there are

Why expanding access to accurate dengue tests is a critical need in Asia Read More ยป

In Asia, divergent patient care journeys make dengue diagnosis a challenge

dengue diagnosis

Across the Asia Pacific region, the patient care journey for a dengue infection varies significantly depending on the structure of the local healthcare system [1]. The primary divide stems from whether care is delivered via a centralised model or a community-based model [1]. Delivering appropriate care for patients infected with the dengue virus is increasingly

In Asia, divergent patient care journeys make dengue diagnosis a challenge Read More ยป

ํ˜„๋Œ€ ๋””์ง€ํ„ธ ๋ณ‘๋ฆฌํ•™์„ ์œ„ํ•œ ํ•„์ˆ˜์ ์ธ ์ฝ” ํŒŒ์ผ๋Ÿฟ๋กœ์„œ์˜ AI: Kunal Sharma ๋ฐ•์‚ฌ์™€์˜ ์งˆ์˜์‘๋‹ต

Bridging the quality gap in digital pathology from pre analytics to AI QA with Dr Kunal Sharma

์ด๋ฒˆ Leaders in Conversation ์—ํ”ผ์†Œ๋“œ์—์„œ๋Š” Roche Diagnostics India์˜ Rishub Gupta ์ด๊ด„ ๋งค๋‹ˆ์ €๊ฐ€ Agilis Diagnostics์˜ ๋ถ€์‚ฌ์žฅ์ธ Kunal Sharma ๋ฐ•์‚ฌ์™€ ํ•จ๊ป˜ ์ธ๋„ ์˜๋ฃŒ ๋ถ„์•ผ์—์„œ ๋””์ง€ํ„ธ ๋ณ‘๋ฆฌํ•™๊ณผ ์ธ๊ณต์ง€๋Šฅ์˜ ํ˜์‹ ์ ์ธ ์—ญํ• ์— ๋Œ€ํ•ด ์ด์•ผ๊ธฐ๋ฅผ ๋‚˜๋ˆ•๋‹ˆ๋‹ค. ์ข…์ข… “์•” ์ „๋ฌธ๊ฐ€”๋กœ ๋ถˆ๋ฆฌ๋Š” Sharma ๋ฐ•์‚ฌ๋Š” ์ข…์–‘ํ•™ ๋ถ„์•ผ์—์„œ์˜ ๋ฆฌ๋”์‹ญ๊ณผ Agilis์˜ ๊ด‘๋ฒ”์œ„ํ•œ ์‹คํ—˜์‹ค ๋„คํŠธ์›Œํฌ๋ฅผ ๋””์ง€ํ„ธํ™”ํ•˜๊ธฐ ์œ„ํ•œ ๊ทธ์˜ ๋…ธ๋ ฅ์— ๋Œ€ํ•ด ์ž์„ธํžˆ ์„ค๋ช…ํ•ฉ๋‹ˆ๋‹ค. ๊ทธ๋Š” ๋””์ง€ํ„ธ ๋ณ‘๋ฆฌํ•™์ด ์–ด๋–ป๊ฒŒ ๊ธฐ์ˆ 

ํ˜„๋Œ€ ๋””์ง€ํ„ธ ๋ณ‘๋ฆฌํ•™์„ ์œ„ํ•œ ํ•„์ˆ˜์ ์ธ ์ฝ” ํŒŒ์ผ๋Ÿฟ๋กœ์„œ์˜ AI: Kunal Sharma ๋ฐ•์‚ฌ์™€์˜ ์งˆ์˜์‘๋‹ต Read More ยป

๋””์ง€ํ„ธ ํˆฌ์—ฌ์™€ ์น˜๋ฃŒ ์•ฝ๋ฌผ ๋ชจ๋‹ˆํ„ฐ๋ง์˜ ๋ฏธ๋ž˜: ์ œ23ํšŒ IATDMCT ํ•™์ˆ ๋Œ€ํšŒ ํ†ต์ฐฐ

therapeutic drug monitoring

์น˜๋ฃŒ์— ์žˆ์–ด ํ•ต์‹ฌ์ ์ธ ์ž„์ƒ์  ๊ณผ์ œ๋Š” ํ”ํžˆ ๋‹ค์Œ๊ณผ ๊ฐ™์€ ๊ฒฐ์ •์ ์ธ ์งˆ๋ฌธ์œผ๋กœ ์š”์•ฝ๋ฉ๋‹ˆ๋‹ค: ์–ผ๋งˆ๋‚˜ ๋งŽ์€ ์–‘์˜ ์•ฝ๋ฌผ์„, ์–ผ๋งˆ๋‚˜ ์˜ค๋žซ๋™์•ˆ ํˆฌ์—ฌํ•ด์•ผ ํ•˜๋Š”๊ฐ€? ๋„ˆ๋ฌด๋‚˜ ์˜ค๋žซ๋™์•ˆ ์ง„์ •ํ•œ ์ •๋ฐ€ ์˜๋ฃŒ๋ฅผ ํ–ฅํ•œ ์—ด๋ง์€ ๊ณ ์ •๋œ ์ผ๊ด„ ํˆฌ์—ฌ ๋ฐฉ์‹๊ณผ ์‹œ๋Œ€์— ๋’ค๋–จ์–ด์ง„ ์•ฝ๋™ํ•™(PK) ๋ชจ๋ธ์˜ ํ•œ๊ณ„์— ๋ถ€๋”ชํ˜€ ์™”์Šต๋‹ˆ๋‹ค. ์ด๋Š” ์ƒ๋ฌผํ•™์  ์ œ์ œ๋‚˜ ๊ฐ•๋ ฅํ•œ ์‹ ์•ฝ ํ™”ํ•ฉ๋ฌผ๊ณผ ๊ฐ™์€ ์ฒจ๋‹จ ์˜์•ฝํ’ˆ์— ๋Œ€์‘ํ•˜๊ธฐ์—๋Š” ๋ถ€์ ํ•ฉํ•˜๊ณ  ๊ฒฝ์ง๋œ ์ฒด๊ณ„์˜€์Šต๋‹ˆ๋‹ค.ย  ํ•˜์ง€๋งŒ ์šฐ๋ฆฌ ์—…๊ณ„๋ฅผ ๋ณ€ํ™”์‹œํ‚ค๊ณ  ์žˆ๋Š”

๋””์ง€ํ„ธ ํˆฌ์—ฌ์™€ ์น˜๋ฃŒ ์•ฝ๋ฌผ ๋ชจ๋‹ˆํ„ฐ๋ง์˜ ๋ฏธ๋ž˜: ์ œ23ํšŒ IATDMCT ํ•™์ˆ ๋Œ€ํšŒ ํ†ต์ฐฐ Read More ยป

Scroll to Top